CLAY B SIEGALL Insider Trading $ALDR ALDER BIOPHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
CLAY B SIEGALL in ALDER BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CLAY B SIEGALL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2019
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CLAY B SIEGALL in ALDER BIOPHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, SGEN, SYBX, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 39.66 | 6,350 | 251,841 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 6.33 | 6,363 | 40,246 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.96 | 6,363 | 25,197 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 4.46 | 6,363 | 28,347 | 0 | |
| Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Sell | U | 18.00 | 31,714 | 570,852 | 0 | 31.7 K to 0 (-100.00 %) |
| May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
| May 25 2018 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 15.50 | 15,000 | 232,500 | 15,000 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 0.99 | 9,090 | 8,999 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 1.65 | 9,090 | 14,999 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 1.27 | 9,090 | 11,499 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 0.99 | 9,090 | 8,999 | 31,714 | 22.6 K to 31.7 K (+40.18 %) |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 1.65 | 9,090 | 14,999 | 22,624 | 13.5 K to 22.6 K (+67.16 %) |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 1.27 | 9,090 | 11,499 | 13,534 | 4.4 K to 13.5 K (+204.55 %) |
| May 26 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 16.90 | 15,000 | 253,500 | 15,000 | |
| Jun 02 2016 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 29.26 | 15,000 | 438,900 | 15,000 | |
| May 21 2015 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 39.66 | 6,350 | 251,841 | 6,350 | |
| May 18 2015 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 0.33 | 18,181 | 6,000 | 0 | |
| May 18 2015 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Sell | S | 39.97 | 20,000 | 799,418 | 4,444 | 24.4 K to 4.4 K (-81.82 %) |
| May 18 2015 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Sell | S | 35.04 | 18,181 | 637,077 | 24,444 | 42.6 K to 24.4 K (-42.65 %) |
| May 18 2015 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 0.33 | 18,181 | 6,000 | 42,625 | 24.4 K to 42.6 K (+74.38 %) |
Page: 1